These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6547995)

  • 1. Breast cancer today.
    Kiang DT; Kennedy BJ
    Minn Med; 1984 Jun; 67(6):333-5, 344. PubMed ID: 6547995
    [No Abstract]   [Full Text] [Related]  

  • 2. [CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer].
    Gottwald G; Szakolczai I
    Orv Hetil; 1983 Jan; 124(2):79-84. PubMed ID: 6687491
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant-preoperative-chemotherapy for breast cancer--preliminary report of the Vancouver trial.
    Ragaz J; Baird R; Rebbeck P; Coldman A; Goldie J
    Prog Clin Biol Res; 1985; 201():77-87. PubMed ID: 3912768
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radio-chemotherapy integration].
    Boidi Trotti A
    Minerva Ginecol; 1985 Jun; 37(6):281-2. PubMed ID: 3839916
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant therapy for breast cancer.
    Flippin TA; Langston HD; Prather JL; Scott DI
    J Ark Med Soc; 1987 May; 83(12):483-4. PubMed ID: 2956244
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.
    Bellon JR; Come SE; Gelman RS; Henderson IC; Shulman LN; Silver BJ; Harris JR; Recht A
    J Clin Oncol; 2005 Mar; 23(9):1934-40. PubMed ID: 15774786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiotherapy of carcinoma of the breast].
    Sinistrero G; Zola P; Sussio M; Giurgola L; Lio V
    Minerva Ginecol; 1985 Jun; 37(6):275-80. PubMed ID: 3839915
    [No Abstract]   [Full Text] [Related]  

  • 9. One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases?
    Sautter-Bihl ML; Sauer R
    Strahlenther Onkol; 2007 Jul; 183(7):357-9. PubMed ID: 17609867
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
    Bellon JR; Shulman LN; Come SE; Li X; Gelman RS; Silver BJ; Harris JR; Recht A
    Cancer; 2004 Apr; 100(7):1358-64. PubMed ID: 15042668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy induced refractory anaemia with ring sideroblasts in carcinoma breast.
    Dhot PS; Sharma MC; Kumar L; Saxena R
    J Assoc Physicians India; 1994 Feb; 42(2):153-4. PubMed ID: 7860480
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical treatment of early breast cancer: chemotherapy].
    Ejlertsen B; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [5 years' results of a CMF protocol (methotrexate, cyclophosphamide, fluorouracil) of adjuvant chemotherapy in breast cancers].
    Horner-Vallet D; Cappelaere P; Delobelle A; Depadt G; Madelain M; Demaille A
    LARC Med; 1984 Nov; 4(9):532-40. PubMed ID: 6549038
    [No Abstract]   [Full Text] [Related]  

  • 15. Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet!
    Samur M; Bozcuk HS
    J Clin Oncol; 2003 Jun; 21(12):2444; author reply 2445-7. PubMed ID: 12805349
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of chemotherapy preceding exclusive conservative loco-regional radiotherapy in breast cancer].
    Baillet F; Housset M; Khayat D; Rozec C; Ucla L; Maulard C; Brunel P; Hu BQ; Delanian S
    Pathol Biol (Paris); 1992 Nov; 39(9):933-4. PubMed ID: 1538940
    [No Abstract]   [Full Text] [Related]  

  • 17. Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer.
    Mortimer J; Livingston RB; Hardesty IJ; Groppe CW; Purvis JD; Gupta M; Flournoy N
    Cancer Treat Rep; 1984; 68(7-8):1017-8. PubMed ID: 6744334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Our experience with cyclophosphamide, methotrexate and 5-fluorouracil in the postoperative treatment of breast carcinoma].
    Cavallaro V; Grasso F; Minutolo V; Turco F; Narbone G; Consoli A
    Chir Ital; 1982 Apr; 34(2):292-306. PubMed ID: 6896473
    [No Abstract]   [Full Text] [Related]  

  • 19. [Initial therapeutic evaluations of 141 patients with carcinoma of the breast under 40 years of age].
    Cosentino D; Cazzaniga F; Scandolaro L; Marelli M; Sgro M; Clerici R; Gallosi D; Lattuada N; Sussi PL
    Chir Ital; 1984 Dec; 36(6):1014-25. PubMed ID: 6549578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer.
    Schrohl AS; Meijer-van Gelder ME; Holten-Andersen MN; Christensen IJ; Look MP; Mouridsen HT; Brünner N; Foekens JA
    Clin Cancer Res; 2006 Dec; 12(23):7054-8. PubMed ID: 17114213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.